Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer. This pilot project for colorectal cancer is part of VICC’s Personalized Cancer Medicine Initiative (PCMI), a program to identify genetic mutations in a patient’s tumor that may be useful in matching the appropriate therapy with each patient. […]
News: Emily Chan
Dr. Emily Chan, a medical oncologist at Vanderbilt-Ingram Cancer Center, discusses hereditary pancreatic cancer and what is done to follow those showing concerns of developing the cancer. She encourages patients to research clinical trials since the current therapies for pancreatic cancer need improvement.